MID1 and prostate carcinoma: Recent findings showed elevated MID1 expression in prostate cancer and alteration of the MID1/a4/PP2A axis in lung adenocarcinoma and MID1 expression levels positively correlate with tumour Gleason scores (Kohler et al., 2014; Zhang et al., 2018).